MUTATIONS IN THE NS5A REGION OF HEPATITIS C VIRUS GENOTYPE 2A AND CORRELATION WITH RESPONSE TO PEGYLATED-INTERFERON-ALPHA 2B AND RIBAVIRIN COMBINATION THERAPY

被引:0
|
作者
Hayashi, Kazuhiko [1 ]
Katano, Yoshiaki [1 ]
Ishigami, Masatoshi [1 ]
Nakano, Isao [1 ]
Goto, Hidemi [1 ]
机构
[1] Nagoya Univ, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
796
引用
收藏
页码:677A / 677A
页数:1
相关论文
共 50 条
  • [21] Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy
    Nakamoto, Shingo
    Imazeki, Fumio
    Arai, Makoto
    Yasui, Shin
    Nakamura, Masato
    Haga, Yuki
    Sasaki, Reina
    Kanda, Tatsuo
    Shirasawa, Hiroshi
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (09): : 21177 - 21190
  • [22] Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load
    Kim, Soo Ryang
    El-Shamy, Ahmed
    Imoto, Susumu
    Kim, Ke Ih
    Sugimoto, Kayo
    Kim, Soo Ki
    Tanaka, Yasuhito
    Hatae, Takashi
    Hasegawa, Yutaka
    Fujinami, Aya
    Ohta, Mitsuhiro
    Hotta, Hak
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2013, 31 (5-6) : 426 - 433
  • [23] Mutations of hepatitis C virus NS5B region and the response to interferon plus ribavirin combination treatment
    Hamano, K
    Sakamoto, N
    Enomoto, N
    Izumi, N
    Asahina, Y
    Kurosaki, M
    Ueda, E
    Tanabe, Y
    Maekawa, S
    Watanabe, M
    GASTROENTEROLOGY, 2004, 126 (04) : A721 - A721
  • [24] Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C
    Poynard, T
    GUT, 2003, 52 (10) : 1532 - 1532
  • [25] A randomized prospective clinical trial comparing pegylated interferon alpha 2a/ribavirin versus pegylated interferon alpha 2b/ribavirin in the treatment of Chronic Hepatitis C
    Sinha, S
    Gulur, P
    Patel, V
    Hage-Nassar, G
    Tenner, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S77 - S78
  • [26] Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Honda, Takashi
    Ishigami, Masatoshi
    Itoh, Akihiro
    Hirooka, Yoshiki
    Ishikawa, Tetsuya
    Nakano, Isao
    Yoshioka, Kentaro
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    LIVER INTERNATIONAL, 2011, 31 (09) : 1359 - 1365
  • [27] Association of interleukin 28B polymorphism and mutations in the NS5A region of hepatitis C virus genotype 2 with interferon responsiveness
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Ishizu, Yoji
    Kuzuya, Teiji
    Honda, Takashi
    Ishigami, Masatoshi
    Itoh, Akihiro
    Hirooka, Yoshiki
    Ishikawa, Tetsuya
    Nakano, Isao
    Yoshioka, Kentaro
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 178 - 183
  • [28] Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy
    Veillon, Pascal
    Payan, Christopher
    Le Guillou-Guillemette, Helene
    Gaudy, Catherine
    Lunel, Francoise
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (08) : 1195 - 1203
  • [29] Antiviral/Immunomodulatory Combination Therapy: Pegylated Interferon Alpha 2a and Ribavirin in Patients with Chronic Hepatitis C Virus Infection
    Delic, Dragan
    Mitrovic, Nikola
    Popovic, Natasa
    Urosevic, Aleksandar
    Pesic, Ivana
    Simonovic, Jasmina
    Dulovic, Olga
    Svirtlih, Neda
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (9-10) : 612 - 618
  • [30] Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection
    Mina Nakagawa
    Naoya Sakamoto
    Mayumi Ueyama
    Kaoru Mogushi
    Satoshi Nagaie
    Yasuhiro Itsui
    Seishin Azuma
    Sei Kakinuma
    Hiroshi Tanaka
    Nobuyuki Enomoto
    Mamoru Watanabe
    Journal of Gastroenterology, 2010, 45 : 656 - 665